All In MedTech

Device Trial Radar · NCT05365607

NightWare and Cardiovascular Health in Adults With PTSD

NightWare Therapeutic Platform for Improving Cardiovascular Health in Adults With Nightmares Associated With PTSD

Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jun 24, 2022

Primary completion

Aug 15, 2024

Study completion Aug 18, 2024

Sponsor

Lead sponsor
University of Colorado, DenverAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Aging (NIA)
First posted
May 9, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular aging and autonomic function in adults with nightmares related to PTSD.

Conditions

  • Posttraumatic Stress Disorder
  • Cardiovascular Diseases
  • Autonomic Dysfunction
  • Vascular Stiffness
  • Nightmare
  • Endothelial Dysfunction

Interventions

  • NightWareDevice

    A wearable digital therapeutic platform consisting of an Apple Watch and iPhone pre-provisioned with Nightware intervention app that will deliver a mild vibration to the watch after detecting individual having a nightmare based on Nightware proprietary algorithm, arousing the individual and disrupting nightmare without awakening.

  • Sham NightWareDevice

    NightWare device will not deliver an intervention (i.e., no vibration)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in large elastic artery stiffness -carotid arteryTime frame: Measured before and after 6 weeks of NightWare and sham conditions
  2. Change in endothelial functionTime frame: Measured before and after 6 weeks of NightWare and sham conditions
  3. Change in 1utonomic function - BRSTime frame: Measured before and after 6 weeks of NightWare and sham conditions

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • University of Colorado CCTSI CTRC

    Denver, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.